AzTrials
AzTrials

Placental TransfusionTerm-NRICNCT02827409

Short-Delay Cord Clamping Compared to Extended- Delay Cord Clamping in Term Neonates That Require Resuscitation.

A study testing Short Delay Cord Clamping and Extended Delay Cord Clamping in people with Placental Transfusion, run by Anup Katheria, M.D. at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To determine whether performing extended delayed cord clamping in term neonates that require resuscitation improves early transition as compared to short-delayed cord clamping. Read more about this study

Who is it for?
Ages 37 to 42 weeks
Conditions the study is for
Placental Transfusion
What is being tested?
Short Delay Cord Clamping and Extended Delay Cord Clamping
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteUnited States
Study dates
Jul 2016to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 37 to 42 weeks
  • All sexes
  • No healthy volunteers
  • Child
  • Inclusion Criteria: Gestation 37 weeks or greater that require attendance at delivery of neonatal provider due to an at risk delivery.
  • Exclusion Criteria: Planned cesarean birth, placental abruption, multiple gestations, or known congenital anomalies.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Sharp Mary Birch Hospital for Women and Newborns

    San Diego, California, 92123

Other trials in United States

About this study

Official title: A Randomized Controlled Trial of Short-Delay Cord Clamping as Compared to Extended- Delayed Cord Clamping in Term Neonates That Require Resuscitation.

To determine whether performing extended delayed cord clamping in term neonates that require resuscitation improves early transition as compared to short-delayed cord clamping.

Read the detailed description

All subjects will receive delayed cord clamping. One group (short-delay) will receive up to one minute of delayed cord clamping and then will be placed either on the mother's abdomen or the life-start trolley if extensive resuscitation is required.

The second group will receive delayed cord clamping for at least 5 minutes and continue until the baby has established breathing without additional support or is stable on respiratory support (no longer received mask PPV for at least 1-2 minutes, i.e. stable on CPAP or intubated). The subject will initially be placed on the mother's abdomen or if the subject needs extensive resuscitation they will be moved to the LifeStart bed to receive resuscitation measures.

In either group if the baby is deemed to be unstable (by medical team) to be on the life-start trolley the cord will be clamped and the baby will be moved to an adjacent warmer for resuscitation.

Being tested
Short Delay Cord Clamping, Extended Delay Cord Clamping
Keywords
Delayed cord clamping
Medical subject headings
Fetofetal Transfusion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Short Delay Cord ClampingProcedure or surgery

    Delay cord clamping will occur for up to 1 minute. Subject will be placed on mother's abdomen for warmth and stimulation. If the subject is depressed they will be transferred to the radiant warmer for resuscitation.

  • Extended Delay Cord ClampingProcedure or surgery

    Extended delay cord clamping will occur for at least 5 minutes and will continue until the subjects begins breathing and/or the cord stops pulsating. Subject will be placed on mother's abdomen for warmth and stimulation. If the subject is depressed they will be transferred to the LifeStart bed for resuscitation adjacent to the mother's bedside.

Study groups in NCT02827409
Study groupRoleWhat they receive
Short Delay Cord ClampingActive comparatorSubject will have umbilical cord clamped and cut by 1 minute of life.
Receives: Procedure: Short Delay Cord Clamping
Extended Delay Cord ClampingActive comparatorSubject will have umbilical cord clamped and cut after at least 5 minutes of delayed cord clamping. Duration of cord clamping after 5 minutes will depend on if the subject is breathing and/or if the cord has stopped pulsating
Receives: Procedure: Extended Delay Cord Clamping

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cerebral tissue oxygenation

    The need for oxygen, positive pressure ventilation, intubation

    Measured: 12 hours of life

Secondary outcomes (14)
  1. Heart rate

    Heart rate obtained by pulse doppler, EKG, oximetry or a combination of all

    Measured: First 5 minutes of life

  2. Oxygen saturation

    data will be averaged over each minute of life

    Measured: over the first 5 minutes of life

  3. delivery room resuscitation

    did the infant require resuscitation such as stimulation to breathe, oxygen, positive pressure ventilation etc.

    Measured: at birth

  4. Blood pressure

    Measured: 12 hours of life

  5. Hemoglobin

    if Hemoglobin oximeter available

    Measured: First 5 minutes of life

  6. Hemoglobin

    if Hemoglobin oximeter available

    Measured: 12 hours of life

  7. Apgar Score

    1, 5 and 10 minute Apgar

    Measured: First 10 minutes of life

  8. Arterial and Venous Umbilical Cord Blood Gases

    Measured: At birth

  9. Need for NICU admission

    Measured: at birth

  10. Need for hypothermia for hypoxic ischemic encepalopathy

    will be assessed by primary physician using defined criteria for hypothermia

    Measured: at birth

  11. Hospitalization days

    Measured: up to 24 weeks

  12. Bilirubin level

    by transcutaneous or serum if available. percentile on curve will be document to adjust for different time frames.

    Measured: 12-48 hours

  13. Neurodevelopmental impairment

    by Ages and Stages questionnaire or Bayley 3scales of infant and toddler development

    Measured: 12 month followup

  14. Post delivery survey

    Survey of practitioners (LD nurse, OB, neonatal team) about procedure

    Measured: at birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2016 (estimated)
  2. Study startJul 2016
  3. Primary completionSep 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02827409
Sponsor's protocol ID
Term-NRIC
Acronym
Term-NRIC
Status last verified
Jun 2017
First submitted
5 Jul 2016
Last updated
8 Jun 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No: small pilot study of term infants

Publications

  • Katheria AC, Brown MK, Faksh A, Hassen KO, Rich W, Lazarus D, Steen J, Daneshmand SS, Finer NN. Delayed Cord Clamping in Newborns Born at Term at Risk for Resuscitation: A Feasibility Randomized Clinical Trial. J Pediatr. 2017 Aug;187:313-317.e1. doi: 10.1016/j.jpeds.2017.04.033. Epub 2017 May 16.

    PubMed 28526223

Questions about this trial

What is this clinical trial studying?

A study testing Short Delay Cord Clamping and Extended Delay Cord Clamping in people with Placental Transfusion, run by Anup Katheria, M.D. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cerebral tissue oxygenation (time frame: 12 hours of life). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02827409, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in